Lifecare ASA (OSL:LIFE)

Market Cap	77.76M -62.3%
Revenue (ttm)	1.83M -87.9%
Net Income	-124.00M
EPS	-7.81
Shares Out	191.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,450,774
Average Volume	4,013,466
Open	0.4400
Previous Close	0.4070
Day's Range	0.4150 - 0.5540
52-Week Range	0.4000 - 23.5000
Beta	-0.59
RSI	30.59
Earnings Date	Mar 3, 2026

About Lifecare ASA

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures pressure, temperature, force, or various other performance indicators in live tissue; and medical devices that remove subdermal implants. Lifecare ASA ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 28
• Stock Exchange: Oslo Børs
• Ticker Symbol: LIFE

Financial Performance

In 2024, Lifecare ASA's revenue was 9.67 million, a decrease of -26.10% compared to the previous year's 13.09 million. Losses were -71.76 million, 103.5% more than in 2023.